12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Blood-derived circulatory angiogenic cells (CACs) and resident cardiac stem cells (CSCs) have both been shown to improve cardiac function after myocardial infarction. The superiority of either cell type has long been an area of speculation with no definitive head-to-head trial. In this study, we compared the effect of human CACs and CSCs, alone or in combination, on myocardial function in an immunodeficient mouse model of myocardial infarction.

          Related collections

          Author and article information

          Journal
          Circulation
          Circulation
          1524-4539
          0009-7322
          Sep 10 2013
          : 128
          : 11 Suppl 1
          Affiliations
          [1 ] University of Ottawa Heart Institute, Department of Cardiology, Ottawa, Ontario, Canada (N.L., B.Y., R.J., B.-K.L., D.K., M.R., E.J.S., D.R.D.); and Ottawa Hospital Research Institute, Department of Medicine, Ottawa, Ontario, Canada (D.J.S.).
          Article
          128/26_suppl_1/S105 CAMS3669
          10.1161/CIRCULATIONAHA.112.000374
          24030393
          7320b77d-678d-4581-94da-2fc94c4a06ad
          History

          blood cells,heart failure,myocardial infarction,stem cells

          Comments

          Comment on this article